| Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 45.95K | C$ 0.00 | C$ 0.00 | C$ 1.23K | C$ 29.24K |
| Gross Profit | C$ 18.31K | C$ -7.28K | C$ -6.57K | C$ 1.23K | C$ 29.24K |
| Operating Income | C$ -1.85M | C$ -1.16M | C$ -770.34K | C$ -264.79K | C$ -1.34M |
| EBITDA | C$ -1.76M | C$ -1.04M | C$ -714.00K | C$ -231.85K | C$ -1.24M |
| Net Income | C$ -1.88M | C$ -1.13M | C$ -746.11K | C$ -253.97K | C$ -1.27M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 106.00 | C$ 5.54K | C$ 20.69K | C$ 1.89K | C$ 596.00 |
| Total Assets | C$ 291.61K | C$ 190.72K | C$ 87.22K | C$ 29.13K | C$ 67.55K |
| Total Debt | C$ 509.98K | C$ 859.32K | C$ 432.12K | C$ 252.32K | C$ 150.96K |
| Net Debt | C$ 509.87K | C$ 853.78K | C$ 411.43K | C$ 250.43K | C$ 150.36K |
| Total Liabilities | C$ 1.79M | C$ 1.55M | C$ 945.28K | C$ 846.05K | C$ 780.00K |
| Stockholders' Equity | C$ -1.50M | C$ -1.36M | C$ -858.06K | C$ -816.92K | C$ -712.45K |
| Cash Flow | |||||
| Free Cash Flow | C$ -370.77K | C$ -664.10K | C$ -254.57K | C$ -89.13K | C$ -48.57K |
| Operating Cash Flow | C$ -370.78K | C$ -660.04K | C$ -238.47K | C$ -87.32K | C$ -48.57K |
| Investing Cash Flow | C$ 0.00 | C$ -4.06K | C$ -16.11K | C$ -1.80K | C$ 0.00 |
| Financing Cash Flow | C$ 365.32K | C$ 641.67K | C$ 273.30K | C$ 90.36K | C$ 44.80K |
CanaQuest Medical Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.